Product Name | MF | CAS | Details |
---|
5-(2-PYRIDYL)-1,2-DIHYDROPYRIDIN-2-ONE | C10H8N2O | 381233-78-9 | Details |
1-Hydroxycyclohexyl phenyl ketone | C13H16O2 | 947-19-3 | Details |
4-(Methylthio)benzaldehyde | C8H8OS | 3446-89-7 | Details |
1-Phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-2-one | C16H12N2O | 381725-50-4 | Details |
Mirabegron Impurity 75 | C23H25N5O2S | 2416733-26-9 | Details |
[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxyphosphonic acid | C10H15N5O10P2 | 1053-73-2 | Details |
Aspartame | C14H18N2O5 | 22839-47-0 | Details |
8-Azabicyclo[3.2.1]octane-3,6-diol, 8-methyl-, (1R,3S,5S,6R)- | C8H15NO2 | 20698-37-7 | Details |
GLORIOSINE | C21H23NO6 | 7411-12-3 | Details |
Cyclobutanecarboxylic acid, 1-[[(1-aminocyclobutyl)carbonyl]amino]- | C10H16N2O3 | 1513077-71-8 | Details |
Benzonitrile, 4-[(1,3-dihydro-1-methoxy-2,1-benzoxaborol-5-yl)oxy]- | C15H12BNO3 | 2368899-47-0 | Details |
Entecavir Impurity 32 | C15H19N5O5 | 1415118-53-4 | Details |
Entecavir Impurity 33 | C15H19N5O5 | 1415118-52-3 | Details |
2-[[(Z)-[1-(2-aMino-4-thiazolyl)-2-[[[(2R,5RS)-5-Methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]Methyl]aMino]-2-oxoethylidene]aMino]oxy]acetic Acid | C15H17N5O6S2 | 1335475-19-8 | Details |
Erioglaucine disodium salt | C37H37N2NaO9S3 | 3844-45-9 | Details |
Nγ-Acetyl-L-2,4-diaminobutyric acid | C6H12N2O3 | 1190-46-1 | Details |
4-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)-3-azetidinyl]-1H-pyrazol-4-yl]-7H-Pyrrolo[2,3-d]pyrimidine-7-carboxylic acid 1,1-dimethylethyl ester | C21H25N7O4S | 2055723-13-0 | Details |
Tamsulosin | C16H19N | 21003-57-6 | Details |
6,7-Dichloro-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester | C15H13Cl2NO3 | 1094412-34-6 | Details |
2-Benzothiazolethiol(9CI) | C7H5NS2 | 118090-09-8 | Details |
IT1tdihydrochloride | C21H35ClN4S2 | 1092776-63-0 | Details |
NCT-58 | C27H34N2O5 | 2411429-33-7 | Details |
NS8593 hydrochloride | C17H17N3.ClH | 875755-24-1 | Details |
PS 210 | C19H15F3O5 | 1221962-86-2 | Details |
PE154 | C35H35N5O4 | 1192750-33-6 | Details |
PF-8380 | C22H21Cl2N3O5 | 1144035-53-9 | Details |
CB2R PAM | C21H24BrFN2O2 | 2244579-87-9 | Details |
WAY-380064-A | C19H22ClNO2 | 380192-76-7 | Details |
Anavex2-73 | C19H24ClNO | 195615-84-0 | Details |
CK869 | C17H16BrNO3S | 388592-44-7 | Details |
FEN1-IN-4 | C12H12N2O3 | 1995893-58-7 | Details |
SRI-011381 | C20H31N3O | 1629138-41-5 | Details |
methyl 2-((tert-butoxycarbonyl)amino)-4-chlorothiazole-5-carboxylate(WX191853) | C10H13ClN2O4S | 804482-36-8 | Details |
ML289 | C22H23NO3 | 1382481-79-9 | Details |
PDE4B-IN-2 | C19H18ClN3O2S | 915082-52-9 | Details |
SR2640 | C23H18N2O3 | 105350-26-3 | Details |
T20 | 146680-14-0 | Details |
MK2-IN-3 | C21H16N4O | 724711-21-1 | Details |
PF 543 | C27H31NO4S | 1415562-82-1 | Details |
NEK6 inibitor 8 | C18H12N2O3 | 591239-68-8 | Details |
IM-54 | C19H23N3O2 | 861891-50-1 | Details |
H2L5186303 | C26H20N2O8 | 139262-76-3 | Details |
INDY | C12H13NO2S | 1169755-45-6 | Details |
BSJ-03-204 | C43H48N10O8 | 2349356-09-6 | Details |
NT-157 | C16H14BrNO5S | 1384426-12-3 | Details |
RO-3306 | C18H13N3OS2 | 872573-93-8 | Details |
OBX02-011 | C29H39ClN8O3S | 2349336-18-9 | Details |
TES-1025 | C18H13N3O3S2 | 1883602-21-8 | Details |
JT010 | C16H19ClN2O3S | 917562-33-5 | Details |
1-[4-(6-nitro-3-pyridinyl)-1-piperazinyl]ethanone | C11H14N4O3 | 852225-20-8 | Details |
SR 11237 | C24H28O4 | 146670-40-8 | Details |
HLY78 | C17H17NO2 | 854847-61-3 | Details |
BVT948 | C14H11NO3 | 39674-97-0 | Details |
MNI137 | C15H9BrN4O | 946619-21-2 | Details |
BAY 1217389 | C27H24F5N5O3 | 1554458-53-5 | Details |
VK-2019 | C29H25NO4 | 2044520-06-9 | Details |
(R)-ZINC-3573 | C18H21N5 | 2089389-15-9 | Details |
H3B-120 | C19H24N4O2S | 2194903-42-7 | Details |
(S)-ZINC-3573 | C18H21N5 | 2095596-11-3 | Details |
LJI308 | C21H18F2N2O2 | 1627709-94-7 | Details |
PSB 1115 | C14H14N4O5S | 152529-79-8 | Details |
SCH 336 | C23H25NO8S3 | 447459-51-0 | Details |
FRAX486 | C25H23Cl2FN6O | 1232030-35-1 | Details |
PF 543 HCl | C27H32ClNO4S | 1706522-79-3 | Details |
Acifran;4,5-Dihydro-5-Methyl-4-oxo-5-phenyl-2-furancarboxylicacid | C12H10O4 | 72420-38-3 | Details |
NXP800 | C32H32FN5O4 | 1693734-80-3 | Details |
CTLA-4 inhibitor | C21H13F4N5O | 635324-72-0 | Details |
Kakeimide | C21H22N2O4 | 928975-34-2 | Details |
ARQ621 | C28H24Cl2FN5O2 | 1095253-39-6 | Details |
SRX3177 | C31H32N6O4S | 2241237-51-2 | Details |
methyl (2-chloroacetyl)glycinate | C17H22O | 726-94-3 | Details |
1H-Pyrazole-3-carboxamide, 5-(1,1-dimethylethyl)-N-(2-hydroxy-1,1-dimethylethyl)-1-[5-(trifluoromethyl)-2-pyridinyl]- | C18H23F3N4O2 | 2374894-45-6 | Details |
UM729 | C20H25N5O2 | 1448723-60-1 | Details |
MRS 1220 | C21H14ClN5O2 | 183721-15-5 | Details |
Ipsapirone | C19H23N5O3S | 95847-70-4 | Details |
KL001 | C21H22N2O4S | 309928-48-1 | Details |
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- | C22H25N3O3 | 404951-53-7 | Details |
AGI-25696 | C27H18N4O | 2201066-35-3 | Details |
GA-017 | C18H21N3O4 | 2351906-74-4 | Details |
GSK2033 | C29H28F3NO5S2 | 1221277-90-2 | Details |
DSM502 | C16H16F3N3O | 2426616-55-7 | Details |
SB-265610 | C14H9BrN6O | 211096-49-0 | Details |
Neuropathiazol;ethyl 4-(methyl(2-phenylthiazol-4-yl)amino)benzoate | C19H18N2O2S | 880090-88-0 | Details |
H-151 | C17H17N3O | 941987-60-6 | Details |
SGC-SMARCA-BRDVIII | C19H25N5O3 | 1997319-84-2 | Details |
CC-90011 | C30H29F2N5O5S | 2097523-60-7 | Details |
4-Ethynyl-N-ethyl-1,8-naphthalimide | C16H11NO2 | 912921-26-7 | Details |
NecroX-7 | C24H29N3O3S | 1120332-55-9 | Details |
Lobeglitazone Sulfate | C24H26N4O9S2 | 763108-62-9 | Details |
JBJ-03-142-02 | C25H22FN7O3 | 2068806-31-3 | Details |
NAV 2729 | C25H17ClN4O3 | 419547-11-8 | Details |
UNC8153 TFA | 2929304-61-8 | Details |
BMX-IN-1 | C29H24N4O4S | 1431525-23-3 | Details |
CVT10216 | C24H19NO7S | 1005334-57-5 | Details |
Product Total: Product Page: | ||||
73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 |